Mindset Wealth Management
KRYS icon

Mindset Wealth Management’s Krystal Biotech KRYS Stock Holding History

Mindset Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$506K Sell
1,522
-78
-5% -$27K 0.09% 97
2026
Q2 		$595K Buy
1,600
+150
+10% +$44.8K 0.11% 89
2026
Q1 		$375K Sell
1,450
-343
-19% -$91.3K 0.1% 106
2025
Q4 		$442K Buy
1,793
+323
+22% +$68K 0.12% 97
2025
Q3 		$259K Buy
+1,470
New +$220K 0.07% 139
2025
Q2 		– Sell
-1,450
Closed -$261K – 158
2025
Q1 		$261K Buy
+1,450
New +$244K 0.1% 104

Other funds holding KRYS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Mindset Wealth Management's KRYS Position: Q3 2026 in Review

Mindset Wealth Management reduced its Krystal Biotech (KRYS) stake by 4.9% in Q3 2026, selling an estimated $27K and leaving 1,522 shares worth $506K. The position accounts for 0.09% of the portfolio, ranked #97.

Mindset Wealth Management first reported a position in KRYS in Q1 2025 and has held it in 6 quarters since. The position peaked at $595K in Q2 2026. 195 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Mindset Wealth Management held 1,522 shares of Krystal Biotech worth $506K as of Q3 2026.
  • Mindset Wealth Management sold 78 Krystal Biotech shares in Q3 2026, an estimated $27K.
  • Krystal Biotech made up 0.09% of Mindset Wealth Management's portfolio in Q3 2026, its #97 holding.
  • Mindset Wealth Management first reported a position in Krystal Biotech in Q1 2025 and has held it in 6 quarters since.
  • Mindset Wealth Management's Krystal Biotech position peaked at $595K in Q2 2026.
  • 195 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Mindset Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.